The SPIONs-CCPMs system developed by Horvat’s team has confirmed that these biomimetic nanoparticles can not only effectively target tumors, but also reprogram the tumor microenvironment and activate the CD8 T-cell immune response [41]. Here, CD8A is linked to neoplasm.